Haleos Labs Limited — promoter holding and stake value

Pharmaceuticals & Biotechnology

The promoter group of Haleos Labs Limited holds 72.11% of the company. At a market capitalisation of ₹423 cr, that holding is worth ₹305 cr.

Promoter stake

72.11%

Value of holding

₹305 cr

Market cap

₹423 cr

Stake change

+4.11%

Promoter stake, quarter by quarter

QuarterHoldingStake %Pledged
Q1-2020
68.00%—
Q3-2021
67.74%—
Q4-2021
67.69%—
Q1-2022
68.96%—
Q2-2022
69.85%—
Q3-2022
69.86%—
Q4-2022
70.32%—
Q1-2023
70.32%—
Q2-2023
70.32%—
Q3-2023
70.32%—
Q4-2023
70.68%—
Q1-2024
71.19%—
Q2-2024
71.41%—
Q3-2024
71.41%—
Q4-2024
71.41%—
Q1-2025
71.41%—
Q2-2025
71.41%—
Q3-2025
71.41%—
Q4-2025
71.80%—
Q1-2026
72.11%—
Q2-2026
72.11%—
Q3-2026
72.11%—

Promoter holdings in Pharmaceuticals & Biotechnology

What this figure is, and is not

The value shown is Haleos Labs Limited's disclosed promoter shareholding multiplied by its current market capitalisation. The shareholding percentage comes from the quarterly pattern filed with the exchanges; the market cap moves daily, so this value moves daily.

A promoter group is usually a family, trust or holding company rather than one individual, and this figure covers only this one listed company. It is not an estimate of any person's net worth, and it excludes any other assets, holdings or liabilities.